[{"id":"dc5b63d1-d71c-461a-9555-93d27bcb4d1c","acronym":"PRO00041908","url":"https://clinicaltrials.gov/study/NCT05038644","created_at":"2021-09-09T13:53:03.633Z","updated_at":"2024-07-02T16:35:11.572Z","phase":"Phase 1","brief_title":"XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia","source_id_and_acronym":"NCT05038644 - PRO00041908","lead_sponsor":"Ehab L Atallah","biomarkers":" CD38","pipe":" | ","alterations":" CD38 expression","tags":["CD38"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD38 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e XmAb968"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 02/02/2022","start_date":" 02/02/2022","primary_txt":" Primary completion: 10/01/2025","primary_completion_date":" 10/01/2025","study_txt":" Completion: 10/01/2026","study_completion_date":" 10/01/2026","last_update_posted":"2024-04-03"}]